Steffen Uffenorde/LinkedIn
Sep 7, 2026, 16:27
Steffen Uffenorde: WHO Consolidated Guidelines for SCD in Children and Adolescents
Steffen Uffenorde, Head of Market Access and Health Economics, Europe and Middle East at Terumo Blood and Cell Technologies; University Lecturer for International HTA, Pricing and Reimbursement, Pharmacoeconomic Evaluation at Hochschule Fresenius, shared a post on LinkedIn:
“WHO consolidated guidelines for the management of Sickle Cell Disease in children and adolescents.
The guideline notes: ‘The choice between exchange and simple RBC transfusion should be guided by clinical urgency, local resource availability and the potential for improved outcomes with exchange transfusion’.”
Stay updated with Hemostasis Today.
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results
-
Oct 27, 2026, 11:42Cece Calhoun: ASH Promotes Clinical Research Training and Mentorship for Emerging Hematologists
-
Oct 27, 2026, 11:41Ifeanyichukwu Ifechidere: The Laboratory Challenges of Measuring Direct Factor Xa Inhibitors
-
Oct 27, 2026, 11:39Gene Therapy Offers New Possibilities for Patients with Thalassaemia in the UAE – Thalassaemia International Federation
-
Oct 27, 2026, 11:35Alan Nurden: rFVIIa Prophylaxis May Reduce Bleeding-Related Healthcare Burden in Glanzmann Thrombasthenia
-
Oct 27, 2026, 10:12Cesar Garrido: WFH Connects with Spanish Thrombosis and Haematology Societies
-
Oct 27, 2026, 10:01Chokri Ben Lamine: CAPS After Autologous SCT – Diagnostic Criteria and Key Mimics
-
Oct 27, 2026, 09:45Jean Terrier: COBRRA Trial – Comparing Bleeding Risks Between DOACs
-
Oct 27, 2026, 08:42Kathleen Freson: SLFN14 at the Crossroads of RNA Regulation, Platelet Biogenesis and Inherited Thrombocytopenia